Monkeypox: EU secures more doses of Bavarian monkeypox vaccine

EU secures more doses of Bavarian monkeypox vaccine The European Union said on Wednesday it had secured an additional 170,920 doses of the monkeypox vaccine developed by biotech firm Bavarian Nordic amid concerns about the outbreak of the disease. Reuters Reuters

...

The additional doses will be available for delivery before the end of the year, while shots that were purchased earlier are currently being distributed, the EU Commission said.